SIGLEC1 and plasma cell myeloma: Mechanistically, the pro-inflammatory cytokines IL-6 and tumor necrosis factor alpha (TNFα) secreted by CD169+TAMs, increase vascular leakage and downregulate CD138-mediated cell adhesion; thus, driving myeloma intravasation (60).